Rating History for Kintara Therapeutics, Inc (KTRA) by Aegis Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/3/2021 Nathan Weinstein Maintain Buy
(N/A)
7.00
(6.00)
 
 
  Details